FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to a method for determining the immunotherapeutic activity of a composition of activated dendritic cells (DC), and can be used in medicine.
EFFECT: proposed method, including determination of relative amounts of IL-6, IL-8, IL-12 and TNFα and comparing them with threshold values, can be used to increase the immunotherapeutic activity of the population of activated dendritic cells and determine the effectiveness of immunotherapy of the patient.
21 cl, 2 tbl, 1 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INTRODUCTION OF DENDRITIC CELLS EXPOSED TO PARTIAL AGING IN VITRO, FOR TUMOUR TREATMENT | 2003 |
|
RU2348418C2 |
| DENDRITIC CELL GENERATION FROM MONOCYTIC DENDRITIC CELL PRE-CURSORS BY MEANS OF GM-CSF IN ABSENCE OF ADDITIONAL CYTOKINES | 2004 |
|
RU2364625C2 |
| METHOD OF ANTITUMOUR IMMUNOTHERAPY | 2012 |
|
RU2530523C2 |
| METHOD OF ENHANCEMENT OF IMMUNE RESPONSE TO ANTIGENE IN MAMMALS | 2004 |
|
RU2341289C2 |
| IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
| CO-DIFFERENTIATION OF MONOCYTES FROM ALLOGENEIC DONORS | 2013 |
|
RU2668816C2 |
| IMPROVED COMPOSITION FOR INHIBITION OF TUMOUR CELL PROLIFERATION | 2011 |
|
RU2565542C2 |
| METHOD OF INDUCING CYTOTOXIC ANTI-TUMOUR IMMUNE RESPONSE in vitro WITH USING DENDRITIC CELLS, TRANSFECTED BY RNA TUMOUR CELLS, TO NON-SMALL CELL LUNG CANCER | 2015 |
|
RU2578008C1 |
| CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
| METHOD OF LOADING DENDRITIC CELLS WITH ANTIGEN OF INFECTIOUS ORIGIN Opistorchis felineus | 2011 |
|
RU2486238C1 |
